SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-025293
Filing Date
2023-07-21
Accepted
2023-07-21 08:25:40
Documents
43
Period of Report
2023-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K avtx-20230720.htm   iXBRL 8-K 33709
2 EX-10.1 ex-101forbearanceagreement.htm EX-10.1 54038
3 EX-99.1 avaloinvestordeckjuly202.htm EX-99.1 33819
7 GRAPHIC avaloinvestordeckjuly202001.jpg GRAPHIC 98503
8 GRAPHIC avaloinvestordeckjuly202002.jpg GRAPHIC 187431
9 GRAPHIC avaloinvestordeckjuly202003.jpg GRAPHIC 137124
10 GRAPHIC avaloinvestordeckjuly202004.jpg GRAPHIC 129505
11 GRAPHIC avaloinvestordeckjuly202005.jpg GRAPHIC 57078
12 GRAPHIC avaloinvestordeckjuly202006.jpg GRAPHIC 136121
13 GRAPHIC avaloinvestordeckjuly202007.jpg GRAPHIC 109018
14 GRAPHIC avaloinvestordeckjuly202008.jpg GRAPHIC 131348
15 GRAPHIC avaloinvestordeckjuly202009.jpg GRAPHIC 98460
16 GRAPHIC avaloinvestordeckjuly202010.jpg GRAPHIC 57927
17 GRAPHIC avaloinvestordeckjuly202011.jpg GRAPHIC 145493
18 GRAPHIC avaloinvestordeckjuly202012.jpg GRAPHIC 142363
19 GRAPHIC avaloinvestordeckjuly202013.jpg GRAPHIC 105295
20 GRAPHIC avaloinvestordeckjuly202014.jpg GRAPHIC 160740
21 GRAPHIC avaloinvestordeckjuly202015.jpg GRAPHIC 62129
22 GRAPHIC avaloinvestordeckjuly202016.jpg GRAPHIC 130491
23 GRAPHIC avaloinvestordeckjuly202017.jpg GRAPHIC 109632
24 GRAPHIC avaloinvestordeckjuly202018.jpg GRAPHIC 120474
25 GRAPHIC avaloinvestordeckjuly202019.jpg GRAPHIC 104152
26 GRAPHIC avaloinvestordeckjuly202020.jpg GRAPHIC 51362
27 GRAPHIC avaloinvestordeckjuly202021.jpg GRAPHIC 85391
28 GRAPHIC avaloinvestordeckjuly202022.jpg GRAPHIC 124473
29 GRAPHIC avaloinvestordeckjuly202023.jpg GRAPHIC 111030
30 GRAPHIC avaloinvestordeckjuly202024.jpg GRAPHIC 49870
31 GRAPHIC avaloinvestordeckjuly202025.jpg GRAPHIC 50087
32 GRAPHIC avaloinvestordeckjuly202026.jpg GRAPHIC 139153
33 GRAPHIC avaloinvestordeckjuly202027.jpg GRAPHIC 116849
34 GRAPHIC avaloinvestordeckjuly202028.jpg GRAPHIC 140125
35 GRAPHIC avaloinvestordeckjuly202029.jpg GRAPHIC 119397
  Complete submission text file 0001628280-23-025293.txt   4696942

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20230720.xsd EX-101.SCH 1969
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20230720_lab.xml EX-101.LAB 24183
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20230720_pre.xml EX-101.PRE 12576
37 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20230720_htm.xml XML 2625
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 231101142
SIC: 2834 Pharmaceutical Preparations